Important note

This AI stock analysis for Teladoc Health is not up to date. Creating and accessing our AI stock Analysis (powered by our data and Chat GPT) is only available for our premium users. Sign up to get access today!

Teladoc Health - AI Stock Analysis

Analysis generated November 16, 2024

Teladoc Health, Inc. (TDOC) is a leading provider of virtual healthcare services, spanning a wide variety of medical disciplines, including non-emergency primary care, mental health, cardiology, and dermatology. The company leverages its platform to provide on-demand remote medical consultations and advice, promoting accessibility and convenience in healthcare. As a pioneer in telehealth, Teladoc has grown substantially over the past decade, backed by its advanced technology platforms and expanding network of healthcare professionals.

Fundamental Analysis

For the most recent quarter, Teladoc reported a revenue of $641 million. This marks a slight decrease of 0.30% compared to the previous quarter. Compared to the same quarter last year, revenue dropped by 2.15%. These figures suggest a need for concern as the company struggles to maintain growth in an increasingly competitive telehealth market.

Net income for the quarter was reported at $33 million, which is a massive 96.03% increase from the previous quarter and a 41.70% increase year-over-year. This is a positive sign of profitability and efficient cost management. On the earnings front, EBITDA came in at $63 million, showing an increase of 108.58% from the previous quarter and a 55.32% increase compared to last year. These numbers indicate healthy operational performance despite declining revenue.

It is worth mentioning that in recent months, some company insiders have been selling their shares, which can be seen as a potentially bearish signal. Insider selling often raises red flags as it may indicate a lack of confidence in the company's future performance.

Technical Analysis

At present, Teladoc's stock price stands at $9.21. This is a decrease of 5.83% from a month ago and a significant 46.36% decline over the past year, highlighting long-term performance concerns. The technical indicators suggest a bearish trend.

The Simple Moving Average (SMA) for the past 10 days is 9.37, slightly lower than the previous SMA10 value of 9.39, indicating a potential downward trend in price movement. Moreover, the Relative Strength Index (RSI) is at 74.7, suggesting that the stock is in an overbought condition and could face downward pressure.

Alternative Data Analysis

Analysing alternative data sources, Teladoc Health currently has 74 open job positions, which represents an 8% decline over the past couple of months. This may indicate efforts to cut costs or improve margins, which is not typically a sign of a growing company. Additionally, the business outlook has dropped by 7% over the same period, which is even more concerning.

In terms of customer acquisition, the estimated number of visitors to Teladoc's webpage has decreased by 27% in the last couple of months, pointing to possible declines in customer interest. Mobile app downloads are also down by 7%, which may signal a loss of customer engagement. Despite these negative trends, Teladoc's Instagram page has seen a 9% increase in followers, suggesting some growing interest in the company's brand. On the other hand, the number of followers on their Twitter page has declined by 1%.

Lastly, the AI score provided by AltIndex which combines fundamental, technical, and alternative data analyses, gives Teladoc Health a score of 44, which translates to a "hold" signal.

Conclusion and Recommendation

In conclusion, Teladoc Health presents a mixed bag of performance indicators. While the company shows strong growth in net income and EBITDA, and a few positive signs in alternative data (like social media followers), the overall trend in revenue, stock price, and alternative data such as job postings and webpage visits are concerning.

Given the current bearish technical indicators, declining revenue, and cautious alternative data signals—from insider selling to reduced customer engagement metrics—investors should approach Teladoc Health with caution. The AltIndex AI score of 44 suggesting a "hold" aligns well with this sentiment. Therefore, it may be wise to hold off on new investments in Teladoc Health until more positive trends confirm a turnaround in the company’s performance.

Disclaimer: This AI stock analysis, generated by an experimental AI tool, is for informational purposes only and not financial advice. Information is based on publicly available data and may not always be accurate or current.